Bioceres Crop Solutions (BIOX) Projected to Post Quarterly Earnings on Thursday

Bioceres Crop Solutions (NASDAQ:BIOX) will likely be announcing its Q1 2027 results on Thursday, November 12th. Analysts expect Bioceres Crop Solutions to post earnings of $0.02 per share for the quarter. Investors may review the information on the company’s upcoming Q1 2027 earnings overview page for the latest details on the call scheduled for Thursday, November 19, 2026 at 8:30 AM ET.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its earnings results on Tuesday, September 15th. The company reported ($0.39) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.33). The firm had revenue of $55.90 million for the quarter, compared to analysts’ expectations of $79.00 million. Bioceres Crop Solutions had a negative return on equity of 41.35% and a negative net margin of 94.76%.

Bioceres Crop Solutions Trading Down 9.6%

BIOX opened at $0.21 on Wednesday. The stock has a market cap of $13.69 million, a PE ratio of -0.06 and a beta of 0.54. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 1.76. The business has a 50 day moving average of $0.32 and a 200-day moving average of $0.44. Bioceres Crop Solutions has a 52 week low of $0.19 and a 52 week high of $2.03.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Bioceres Crop Solutions has an average rating of “Reduce” and a consensus price target of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. The company serves farmers and agricultural businesses through products designed to support crop establishment, nutrition, protection and performance under challenging environmental conditions. Its portfolio includes the HB4 biotechnology platform, which is used in drought-tolerant wheat and soybean varieties, as well as biological seed treatments, microbial inoculants, biofertilizers, biostimulants and biological crop-protection products.